In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections

CONCLUSIONS: RSV-IG and ribavirin use in immunocompromised patients requires further study.PMID:37542818 | DOI:10.1016/j.virol.2023.07.007

Source: Virology - August 5, 2023 Category: Virology Authors: Kacy A Ramirez James Mond Jesse Papenburg Guy Boivin Brian E Gilbert Ann R Falsey Bindiya Bagga John P DeVincenzo Source Type: research